Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...
JNJ Unit Ordered to Cough Up $1.64B for Illegal Promotion of HIV Drugs
A unit of medical group Johnson & Johnson (JNJ) has been ordered to pay $1.64 billion for illegally promoting the HIV drugs ...
J&J Win Blocking Mylan Schizophrenia Treatment Upheld on Appeal
Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit convinced a federal appeals court Mylan Laboratories Ltd.’s planned ...
J&J unit ordered to pay $1.64B in HIV drug marketing case, Reuters reports
A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64B after a jury found it liable in a ...
The Pharma Letter12d
Nanobiotix boosted by amended deal with J&J
Shares of French late-stage clinical biotech firm Nanobiotix (Euronext: NAN) leapt 17.6% to 3.47 euros after it announced the ...
Healio4d
Daratumumab regimen improves survival in transplant-ineligible multiple myeloma
The addition of subcutaneous daratumumab to triplet therapy improved outcomes for certain patients with newly diagnosed ...
Yahoo Finance3d
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
The June 13, 2024 verdict followed a six-week trial. Janssen had sought a new trial, saying the verdict was tainted by a lack of proof and by erroneous jury instructions. Neither Johnson & Johnson nor ...